ClinConnect ClinConnect Logo
Search / Trial NCT02775877

Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer

Launched by NAVY GENERAL HOSPITAL, BEIJING · May 15, 2016

Trial Information

Current as of July 21, 2025

Unknown status

Keywords

Pcos Letrozole Clomiphene

ClinConnect Summary

To evaluate the efficacy of letrozole and clomiphene in PCOS patients is important,especially in resistent PCOS patients. Although most medications prove the effectiveness of letrozole and clomiphene,the subjects of letrozole and sequential clomiphene in PCOS patients are rarely.The trial may provide further basis for this medication in PCOS patients in ovulation. If the medication demonstrates efficacy, the method would help the patients with PCOS to deal with the problem of infertility.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with PCOS
  • Exclusion Criteria:
  • •Women more than 38 years or less than 20 years
  • With infectious diseases or endocrine diseases
  • Who refuse to participate in the experiment

About Navy General Hospital, Beijing

Navy General Hospital in Beijing is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a leading sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, aiming to enhance patient outcomes and contribute to medical knowledge. With a robust infrastructure, a team of experienced researchers, and a commitment to ethical standards, Navy General Hospital fosters collaborations with various stakeholders to ensure the successful execution of clinical trials that address pressing health challenges.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Aiming Wang, Dr

Principal Investigator

Navy General Hospital, Beijing

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials